Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed Dec 1, 2015 · 10-Q · 62 days after period end · 0001393905-15-000641
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $58.17K | $52.62K | $125.91K | $49.06K |
| Net Income | -$295.74K | -$791.95K | -$718.84K | -$601.88K |
| EPS Diluted | -$0.03 | -$0.10 | -$0.12 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Dec 1, 2015 · 62 d after period end
